Akili Raises Additional $13 Million, Bringing Total Series C Fundingto $68 Million BOSTON, August 9, 2018-- AkiliInteractive (“Akili” or “Company"), a leading prescription digitalmedicine company developing novel treatments for cognitive dysfunctionand brain-related conditions, has raised $13 million in new funding asan extension of its Series C financing, which was announced in May. Theadditional funds bring the total equity capital Akili has raised thisyear to $68 million. Participating investors include CLSA, OmidyarTechnology Ventures, Digital Garage Group (DG Incubation & DG DaiwaVentures) and Fearless Ventures.